Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
Yongxing BaoXu YangYu MenJingjing KangXin SunMaoyuan ZhaoShuang SunMeng YuanZeliang MaZhouguang HuiPublished in: Thoracic cancer (2021)
For patients with ypN2 NSCLC after NCS, PORT significantly improves OS and CSS. These results need to be confirmed by further randomized studies.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- lymph node
- sentinel lymph node
- rectal cancer
- small cell lung cancer
- minimally invasive
- early stage
- double blind
- public health
- patients undergoing
- open label
- squamous cell carcinoma
- radiation therapy
- coronary artery bypass
- placebo controlled
- emergency department
- risk factors
- radiation induced
- clinical trial
- coronary artery disease
- adverse drug
- surgical site infection
- free survival
- acute coronary syndrome
- percutaneous coronary intervention